全文获取类型
收费全文 | 6502篇 |
免费 | 301篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 621篇 |
妇产科学 | 98篇 |
基础医学 | 724篇 |
口腔科学 | 155篇 |
临床医学 | 470篇 |
内科学 | 1123篇 |
皮肤病学 | 110篇 |
神经病学 | 342篇 |
特种医学 | 197篇 |
外科学 | 904篇 |
综合类 | 150篇 |
一般理论 | 2篇 |
预防医学 | 478篇 |
眼科学 | 252篇 |
药学 | 535篇 |
中国医学 | 33篇 |
肿瘤学 | 502篇 |
出版年
2022年 | 106篇 |
2021年 | 183篇 |
2020年 | 119篇 |
2019年 | 155篇 |
2018年 | 136篇 |
2017年 | 108篇 |
2016年 | 170篇 |
2015年 | 150篇 |
2014年 | 260篇 |
2013年 | 297篇 |
2012年 | 422篇 |
2011年 | 417篇 |
2010年 | 291篇 |
2009年 | 198篇 |
2008年 | 317篇 |
2007年 | 333篇 |
2006年 | 343篇 |
2005年 | 312篇 |
2004年 | 245篇 |
2003年 | 237篇 |
2002年 | 178篇 |
2001年 | 92篇 |
2000年 | 68篇 |
1999年 | 77篇 |
1998年 | 55篇 |
1997年 | 40篇 |
1996年 | 47篇 |
1995年 | 36篇 |
1992年 | 63篇 |
1991年 | 63篇 |
1990年 | 44篇 |
1989年 | 71篇 |
1988年 | 47篇 |
1987年 | 56篇 |
1986年 | 63篇 |
1985年 | 49篇 |
1984年 | 41篇 |
1982年 | 37篇 |
1981年 | 39篇 |
1980年 | 41篇 |
1979年 | 55篇 |
1978年 | 40篇 |
1977年 | 37篇 |
1976年 | 42篇 |
1975年 | 53篇 |
1974年 | 61篇 |
1973年 | 42篇 |
1971年 | 46篇 |
1970年 | 47篇 |
1967年 | 35篇 |
排序方式: 共有6827条查询结果,搜索用时 15 毫秒
991.
The observation of an apparently non-clonal abnormal cell in a cytogenetic study for a hematologic neoplasm opens the possibility of a small, or slowly proliferating, abnormal clone. Many laboratories analyze additional cells or reflex to fluorescence in situ hybridization (FISH) to evaluate this possibility further. In a retrospective study of 500 cases with a non-clonal abnormal cell identified in a 20-cell analysis, we found that the benefit of additional metaphase analysis was limited to specific categories of abnormal karyotypes, including those with a complex karyotype or a classic abnormality known to be a recurring finding in hematologic neoplasms, and excluding all other categories. 相似文献
992.
993.
Rickson C. Mesquita Steven S. Schenkel David L. Minkoff Xiangping Lu Christopher G. Favilla Patrick M. Vora David R. Busch Malavika Chandra Joel H. Greenberg John A. Detre A. G. Yodh 《Biomedical optics express》2013,4(7):978-994
A pilot study explores relative contributions of extra-cerebral (scalp/skull) versus brain (cerebral) tissues to the blood flow index determined by diffuse correlation spectroscopy (DCS). Microvascular DCS flow measurements were made on the head during baseline and breath-holding/hyperventilation tasks, both with and without pressure. Baseline (resting) data enabled estimation of extra-cerebral flow signals and their pressure dependencies. A simple two-component model was used to derive baseline and activated cerebral blood flow (CBF) signals, and the DCS flow indices were also cross-correlated with concurrent Transcranial Doppler Ultrasound (TCD) blood velocity measurements. The study suggests new pressure-dependent experimental paradigms for elucidation of blood flow contributions from extra-cerebral and cerebral tissues.OCIS codes: (170.3880) Medical and biological imaging, (170.2655) Functional monitoring and imaging, (170.3660) Light propagation in tissues, (170.6480) Spectroscopy, speckle 相似文献
994.
Purpose
To demonstrate usefulness of ultrasonography evaluation of the nerves of the elbow and of the structures that more frequently might cause its compression.Materials and methods
Anatomic course of nerves, muscles, tendons, fibrous structures and bursae potentially associated with nerve compression syndromes were evaluated. Informed consent was obtained from each volunteer.Results
Ulnar, median and radial nerves are always evaluable with ultrasonography as well as muscles and tendons potentially associated with nerve compression. The bursae cannot be sonographically explored unless distended by fluid.Conclusion
Ultrasonography is a reliable method for the evaluation of the nerves of the elbow and of the structures that might cause its compression.Electronic supplementary material
The online version of this article (doi:10.1007/s40477-013-0029-6) contains supplementary material, which is available to authorized users. 相似文献995.
Lindsay S. Mayberry Jeffrey S. Gonzalez Kenneth A. Wallston Sunil Kripalani Chandra Y. Osborn 《Diabetes research and clinical practice》2013
Aims
The Adherence to Refills and Medications Scale (ARMS) has been associated with objective measures of adherence and may address limitations of existing self-report measures of diabetes medication adherence. We modified the ARMS to specify adherence to diabetes medicines (ARMS-D), examined its psychometric properties, and compared its predictive validity with HbA1C against the most widely used self-report measure of diabetes medication adherence, the Summary of Diabetes Self-Care Activities medications subscale (SDSCA-MS). We also examined measurement differences by age (<65 vs. ≥65 years) and insulin status.Methods
We administered self-report measures to 314 adult outpatients prescribed medications for type 2 diabetes and collected point-of-care HbA1C.Results
One of the 12-item ARMS-D items was identified as less relevant to adherence to diabetes medications and removed. The 11-item ARMS-D had good internal consistency reliability (α = 0.86), maintained its factor structure, and had convergent validity with the SDSCA-MS (rho = −0.52, p < 0.001). Both the ARMS-D (β = 0.16, p < 0.01) and the SDSCA-MS (β = −0.12, p < 0.05) independently predicted HbA1C after adjusting for covariates, but this association did not hold among participants ≥65 years in subgroup analyses. There were no differences in ARMS-D or SDSCA-MS scores by insulin status, but participants on insulin reported more problems with adherence on two ARMS-D items (i.e., feeling sick and medicine costs).Conclusions
The ARMS-D is a reliable and valid measure of diabetes medication adherence, and is more predictive of HbA1C than the SDSCA-MS, but takes more time to administer. The ARMS-D also identifies barriers to adherence, which may be useful in research and clinical practice. 相似文献996.
TAN Song NIU Hui-xia ZHAO Lu GAO Yuan LU Jia-meng SHI Chang-he Chandra Avinash 《中华医学杂志(英文版)》2013,126(11):2045-2048
Background The Scale for the Assessment and Rating of Ataxia (SARA) was shown to be a reliable and valid measurement for patients with spinocerebellar ataxia (SCA).The Brazilian version and the Japanese version of SARAwere favorable for good reliability and validity.This study aimed to translate SARA into Chinese and test its reliability and validity in measurement of cerebellar ataxia.Methods SARA was translated into Chinese.A total 39 patients with degeneration cerebellar ataxia were evaluated independently by two neurologists with the Chinese version of SARA.Then the patients were evaluated by one of above neurologists with International Cooperative Ataxia Rating Scale (ICARS).The statistical analyses were performed using SPSS 17.0 for Windows.Results The Cronbach's alpha coefficient of the Chinese version of SARA was 0.78,which represents a good internal consistence.The correlation coefficient of the Chinese version of SARA scores between the two evaluators was 0.86,illustrating that the inter-rater reliability of Chinese version of SARA was good.The correlation coefficient between the Chinese version of SARA and ICARS was 0.91,illustrating that the criterion validity of Chinese version of SARA was not bad.Conclusions The Chinese version of SARA is reliable and effective for the assessment of degeneration cerebellar ataxia.Compared with ICARS,the evaluation of Chinese version of SARA is more objective,the assessment time is shortened,and the maneuverability is better. 相似文献
997.
Jitender Madan Ravi Shankar Pandey Vikas Jain Om Prakash Katare Ramesh Chandra Anju Katyal 《Nanomedicine : nanotechnology, biology, and medicine》2013,9(4):492-503
Noscapine crosses blood–brain-barrier and inhibits proliferation of glioblastoma cells. However, short plasma half-life and rapid elimination necessitate the administration of multiple injections for successive chemotherapy. Noscapine bearing solid lipid nanoparticles, Nos-SLN and poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine, Nos-PEG-SLN of 61.3 ± 9.3-nm and 80.5 ± 8.9-nm containing 80.4 ± 3.2% and 83.6 ± 1.2% of Nos, were constructed. First order kinetic and Higuchi equation were followed to release the Nos at intracellular pH ~ 4.5. Further, a decrease in IC50 (Nos; 40.5 μM > Nos-SLN; 27.2 μM > 20.8 μM) and enhanced subG1 population were observed in U87cells. Plasma half-life was enhanced up to ~ 11-fold and ~ 5-fold by Nos-PEG-SLN and Nos-SLN which significantly (P < 0.05) deposits 400.7 μg/g and 313.1 μg/g of Nos in comparison to 233.2 μg/g by drug solution. This is first report demonstrating a workable approach to regulate the administration of multiple injections of Nos, warranting further in vivo tumor regression study for superior management of brain cancer.From the Clinical EditorThis report describes a possible approach to regulate the administration of multiple injections of Noscapine using solid lipid nanoparticles. The data warrant further in vivo tumor regression studies for optimal management of glioblastoma, a generally very poorly treatable brain cancer. 相似文献
998.
Chandra S. Boosani Palanikumar Gunasekar Devendra K. Agrawal 《Expert opinion on therapeutic patents》2013,23(11):881-889
ABSTRACTIntroduction: A multitude of cellular and physiological functions have been attributed to the biological activity of PTEN (Phosphatase and tensin homolog) such as inhibiting angiogenesis, promoting apoptosis, preventing cell proliferation, and maintaining cellular homeostasis. Based on whether cell growth is needed to be initiated or to be inhibited, enhancing PTEN expression or seeking to inhibit it was pursued.Areas covered: Here the authors provide recent updates to their previous publication on ‘PTEN modulators: A patent review’, and discuss on new specificities that affirm the therapeutic potential of PTEN in promoting neuro-regeneration, stem cell regeneration, autophagy, bone and cartilage regeneration. Also, targeting PTEN appears to be effective in developing new treatment strategies for Parkinson’s disease, Alzheimer’s disease, macular degeneration, immune disorders, asthma, arthritis, lupus, Crohn’s disease, and several cancer types.Expert opinion: PTEN mainly inhibits the PI3k/Akt pathway. However, the PI3k/Akt pathway can be activated by other signaling proteins. Thus, novel treatment strategies that can regulate PTEN alone, or combinational treatment approaches that can induce PTEN and simultaneously affect downstream mediators in the PI3K/Akt pathway, are needed, which were not investigated in detail. Commercial interests associated with molecules that regulate PTEN are discussed here, along with limitations and new possibilities to improve them. 相似文献
999.
Laxmi Manral Natrajan Muniappan Pradeep K. Gupta Kumaran Ganesan Ramesh Chandra Malhotra Rajagopalan Vijayaraghavan 《Drug and chemical toxicology》2013,36(2):108-113
The breathing pattern of mice that were exposed to fentanyl aerosol was studied (2.7, 5.7, 6.0, 10.0, and 23.6 μg/m3; for 1 hour), using dimethyl sulfoxide as a vehicle. This study was conducted in a head-only exposure assembly. Body plethysmographs connected to a volumetric pressure transducer were used to capture the respiratory signals, and an on-line computer program capable of recognizing the changes in the breathing pattern was used for monitoring the respiratory pattern. The response of mice to fentanyl exposure was found to be concentration dependent. A lower concentration (2.7 μg/m3) showed fast recovery and no mortality, while 100% mortality was observed at a higher concentration (23.6 μg/m3). No sensory, pulmonary irritation, and airway limitation in mice was observed, and death occurred probably due to respiratory depression. The concentration that decreased 50% of the respiratory frequency (RD50) was estimated to be 6.4 μg/m3. The extrapolated human threshold limit value, calculated from the RD50 value, was found to be 0.192 μg/m3. The concentration that caused 50% mortality in exposed mice (LC50) was estimated to be 8.8 μg/m3. This study shows that aerosolized fentanyl does not cause sensory and pulmonary irritation, and since the RD50 and LC50 are very close with a low safety margin, this type of sedative should not be used as an incapacitating agent. 相似文献
1000.
Arti Patel Papiya Bigoniya Chandra Shekhar Singh Narayan Singh Patel 《Indian journal of pharmacology》2013,45(3):237-243